This protocol describes a survey undertaken to acquire a snapshot of the distribution of Clostridioides difficile strains in tertiary acute care hospitals in the European Union/European Economic Area (EU/EEA) in 2022–2023
This reporting protocol is for the 2024 data call for antimicrobial resistance (AMR) surveillance data, collected by the European Antimicrobial Resistance Surveillance Network (EARS-Net) for 2023.
This is an operational document for those undertaking trend analyses using regression models. It provides guidance so that experts can carry out a trend analysis independently and understand when extra statistical support is needed.
This protocol sets out measures for the follow-up and management of individuals exposed to infected animals and human cases of avian influenza, and for the public health management of possible and confirmed human cases.
This document provides an update on the safety of substances of human origin (SoHO) in relation to COVID-19. It reassesses the risk and proposes revised mitigation measures for preventing transmission through SoHO.
Sample size calculation is an essential step in ensuring that analysis of the data which are collected through urveillance systems can support the desired public health objective(s). The main aim of sample size calculations is to determine the sample size needed from the population under study to possibly detect a statistically significant result.
This document describes how to strengthen surveillance in hospital settings for the identification of severely affected patients infected with avian influenza virus in the EU/EEA.
The purpose of this guide is to complement the handbook published in 2014 by offering practical, operational
guidance on how to design, develop, conduct and evaluate tabletop and functional exercises.
Since 16 May 2022, and as of 4 April 2023, 21 170 cases of mpox (formerly known as monkeypox) have been reported by countries within the European Union/European Economic Area (EU/EEA).
This assessment tool, which will be used during the country visits to Western Balkans and Türkiye, aims to provide ECDC with a good understanding of national communicable disease surveillance systems.